Knowing the Enemy: Strategic Targeting of Complement to Treat Alzheimer Disease

The authors provide justification, largely from preclinical mouse models but also from correlates with human tissue and biomarkers, for targeting specific complement components for therapeutic intervention in Alzheimer disease.